IDEXX Laboratories, Inc. (NASDAQ:IDXX) is one of the best medical technology stocks to buy right now. On May 19, IDEXX ...

Family history of kidney failure was significantly associated with chronic kidney disease progression, regardless of genetic ...

An asthma drug called formoterol may help reverse MASH-related liver damage, prompting new clinical trials after promising ...

A new blood test approach could detect vascular damage earlier than ever before, helping identify heart and kidney disease ...

She is a mother, competitive dance champion, kidney transplant recipient and Vanderbilt Health nurse. Culp has worked at the Vanderbilt Heart and ...

Supported by peer-reviewed studies using the IDEXX SDMA™ Test, SDMA is recognized by the International Renal Interest Society ...

Please provide your email address to receive an email when new articles are posted on . NKF’s CKDintercept enabled CKD testing for more than 2 million people in a 2 ...

Nobody in Sharron Rouse’s family had ever had kidney disease. There was no warning, no history to trace, and no blueprint for what came next. That gap is exactly what she has spent years trying to ...

Background and objective Kidney transplant recipients (KTRs) face elevated cardiovascular risk, partly due to reduced cardiorespiratory fitness (CRF). Cardiopulmonary exercise testing (CPET), the gold ...

A new blood test can identify which individuals of African ancestry carrying high-risk APOL1 gene variants are most likely to develop kidney failure, years before clinical disease becomes apparent.

A new blood test can identify which individuals of African ancestry carrying high-risk APOL1 gene variants are most likely to develop kidney failure, years before clinical disease becomes apparent.